ReviewCurrent gastroenterology reports2017
Strategies to Reduce 30-Day Readmissions in Patients with Cirrhosis.
Review in Current gastroenterology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.
- EASL position paper on palliative care in advanced chronic liver disease.JHEP reports : innovation in hepatology · 2026Guideline
- A qualitative enquiry into participants' and practitioners' experiences in the Australian Liver FaIlurE trial.BMJ open · 2025Trial
- Randomized intervention and outpatient follow-up lowers 30-d readmissions for patients with hepatic encephalopathy, decompensated cirrhosis.World journal of hepatology · 2023Trial
- Standardization of the Cirrhosis Admission Process and Its Impact on Inpatient Management and Patient Outcomes.Liver international : official journal of the International Association for the Study of the Liver · 2026Article
- Missed diagnosis of cirrhosis in the inpatient setting.Journal of hospital medicine · 2022Review
- Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis.Annals of translational medicine · 2021Article
- Reducing readmissions in patients with cirrhosis: the time to act is now.Annals of translational medicine · 2021Article
- Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials.Florence Nightingale journal of nursing · 2021Review
- Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study.Journal of medical Internet research · 2021Article
- Lower household income is associated with an increased risk of hospital readmission in patients with decompensated cirrhosis.Journal of gastroenterology and hepatology · 2021Article
- Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020Review
- Burden of Cirrhosis on Patients and Caregivers.Hepatology communications · 2020Review
- Acceptance and use of a smartphone application in cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2020Article
- The cirrhosis care Alberta (CCAB) protocol: implementing an evidence-based best practice order set for the management of liver cirrhosis - a hybrid type I effectiveness-implementation trial.BMC health services research · 2020Article
- Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort.Alimentary pharmacology & therapeutics · 2019Article
- Concise Commentary: Remaining Outside the Hospital Is a Golden State in Cirrhosis-Lessons from California.Digestive diseases and sciences · 2018Article
- Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.Digestive diseases and sciences · 2018Article
- Healthcare utilization after liver transplantation is highly variable among both centers and recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2018Article
- A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.Digestive diseases and sciences · 2017Article
- Predictive markers in estimating the need for early intensive care in patients with adhesive small bowel obstruction in the emergency department.Journal of minimal access surgeryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewApproximately, one quarter of patients discharged after a hospitalization for decompensated cirrhosis will be readmitted within 30 days. These readmissions have been associated with increased morbidity and mortality, can be financially harmful to the health system, and may be partially preventable. This review summarizes the literature on readmissions, providing clinicians with tools for risk prediction and a taxonomy for preventative interventions. RECENT
findingsReadmission strategies can be categorized according to complexity (simple versus complex) and specificity (focused versus broad). The literature thus far provides the following generalizable inferences: 1) Interventions should be integrated in the clinical workflow, 2) default options are more powerful than voluntary actions, 3) knowledge improvement should focus on the front line clinicians, 4) process improvements do not always translate into better outcomes, and 5) any successful intervention must include viable alternatives to hospitalization. A growing body of literature provides concrete and actionable guidance for interventions to reduce readmissions in patients with cirrhosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.